27 related articles for article (PubMed ID: 2924721)
1. Synthesis and Biological Evaluation of Chalconesulfonamides: En Route to Proapoptotic Agents with Antiestrogenic Potency.
Krymov SK; Salnikova DI; Dezhenkova LG; Bogdanov FB; Korlyukov AA; Scherbakov AM; Shchekotikhin AE
Pharmaceuticals (Basel); 2023 Dec; 17(1):. PubMed ID: 38256865
[TBL] [Abstract][Full Text] [Related]
2. Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures.
Abderrahman B; Jordan VC
Cancer J; 2022 May-Jun 01; 28(3):163-168. PubMed ID: 35594462
[TBL] [Abstract][Full Text] [Related]
3. Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer.
Maximov PY; Fan P; Abderrahman B; Curpan R; Jordan VC
Front Endocrinol (Lausanne); 2022; 13():869562. PubMed ID: 35360069
[TBL] [Abstract][Full Text] [Related]
4. Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team.
Jordan VC
Breast Cancer Res Treat; 2021 Nov; 190(1):19-38. PubMed ID: 34398352
[TBL] [Abstract][Full Text] [Related]
5. The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.
Fan P; Maximov PY; Curpan RF; Abderrahman B; Jordan VC
Mol Cell Endocrinol; 2015 Dec; 418 Pt 3(0 3):245-63. PubMed ID: 26052034
[TBL] [Abstract][Full Text] [Related]
6. A model to describe how a point mutation of the estrogen receptor alters the structure-function relationship of antiestrogens.
Jiang SY; Parker CJ; Jordan VC
Breast Cancer Res Treat; 1993; 26(2):139-47. PubMed ID: 8219251
[TBL] [Abstract][Full Text] [Related]
7. [MECHANISM OF ACTION OF ESTROGENIC HORMONES].
VELLE W
Tidsskr Nor Laegeforen; 1963 Oct; 83():1528-33. PubMed ID: 14053905
[No Abstract] [Full Text] [Related]
8. Estrogens and the regulation of glucose metabolism.
Alemany M
World J Diabetes; 2021 Oct; 12(10):1622-1654. PubMed ID: 34754368
[TBL] [Abstract][Full Text] [Related]
9. Regulation of prolactin synthesis in vitro by estrogenic and antiestrogenic derivatives of estradiol and estrone.
Jordan VC; Koch R
Endocrinology; 1989 Apr; 124(4):1717-26. PubMed ID: 2924721
[TBL] [Abstract][Full Text] [Related]
10. Estrogen-stimulated prolactin synthesis in vitro. Classification of agonist, partial agonist, and antagonist actions based on structure.
Jordan VC; Lieberman ME
Mol Pharmacol; 1984 Sep; 26(2):279-85. PubMed ID: 6541293
[TBL] [Abstract][Full Text] [Related]
11. Differential interactions of estrogens and antiestrogens at the 17 beta-hydroxy or counterpart function with the estrogen receptor.
Borgna JL; Scali J
Eur J Biochem; 1991 Aug; 199(3):575-85. PubMed ID: 1868844
[TBL] [Abstract][Full Text] [Related]
12. Ligand interaction at the estrogen receptor to program antiestrogen action: a study with nonsteroidal compounds in vitro.
Jordan VC; Koch R; Langan S; McCague R
Endocrinology; 1988 Apr; 122(4):1449-54. PubMed ID: 3345720
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
14. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
